Published in JAMA Network Open · View the paper (DOI)
A study investigated the association between icatibant, a bradykinin 2 receptor antagonist, and improved oxygenation in COVID-19 patients. The findings suggest that icatibant may be beneficial in treating COVID-19 by improving oxygenation, and more research is needed to confirm these results.
Coverage from 2 institutions